HealthIndia · NoidaMay 18, 2026

Cellogen Therapeutics raises $2.3M (India, May 2026)

$2.3M
Rs 20 crore
Browse investors in India →
Generated social card
Cellogen Therapeutics social card
Headline

Cellogen Therapeutics raises Rs 20 crore from Kotak Alts to advance CAR-T cancer therapies - Indian Startup News

About

Cellogen Therapeutics is an Indian biotech startup that develops cell and gene therapies using Chimeric Antigen Receptor T-cell (CAR-T) technology to treat cancers and blood disorders. The company aims to make advanced therapies more accessible and affordable, addressing the high costs associated with existing CAR-T treatments.

Article summary

Cellogen Therapeutics raises Rs 20 crore from Kotak Alts to advance CAR-T cancer therapies  Indian Startup News

Founder
Gaurav Kharya
Gaurav Kharya
Co-Founder
Investors · 1
Kotak Alternate Asset ManagersLead
FUND
Related rounds
Jun 11, 2026$480K—India
Jun 11, 2026FirstClub Technology$55.0MSeries BIndia
Jun 11, 2026Manam Chocolate$9.0MSeries AIndia
Jun 11, 2026QubeHealth-Pay$50.0MSeries AIndia
Cellogen Therapeutics raises $2.3M (India, May 2026) | Datapile